Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19
Background: The nitazoxanide plus atazanavir/ritonavir for COVID-19 (NACOVID) trial investigated the efficacy and safety of repurposed nitazoxanide combined with atazanavir/ritonavir for COVID-19. Methods: This is a pilot, randomized, open-label multicenter trial conducted in Nigeria. Mild to modera...
Saved in:
| Format: | Article |
|---|---|
| Published: |
2022-09
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|